Bezlotoxumab as Treatment for Recurrent/Chronic Clostridioides difficile Infection in Pediatric Stem Cell Transplant Recipients: A Multi‐Institutional Experience

Documenti analoghi

• Treatment of a Pediatric Patient with Core Binding Factor Acute Myeloid Leukemia Post‐Cytotoxic Therapy With Cytarabine, Daunorubicin, and Gemtuzumab Followed by Stem Cell Transplantation
  di: Irtiza N. Sheikh, et al.
  Pubblicazione: (2024)
• Post‐Transplant Cyclophosphamide for Graft‐Versus‐Host Disease Prophylaxis in Pediatric Stem Cell Transplantation
  di: Aaron E. Fan, et al.
  Pubblicazione: (2025)
• Gemcitabine, Docetaxel, Melphalan, Carboplatin as Part of Sequential Cycles of High‐Dose Chemotherapy With Autologous Hematopoietic Stem‐Cell Rescue for Multiply Relapsed/Refractory Pediatric Germ Cell Tumors
  di: Maria Frost, et al.
  Pubblicazione: (2026)
• Comparison of Letermovir Versus Ganciclovir for Cytomegalovirus Prophylaxis in Pediatric Hematopoietic Stem Cell Transplant Recipients
  di: Catherine E. Martin, et al.
  Pubblicazione: (2025)
• Nirsevimab for Prevention of RSV Infections for Immunocompromised Children With Cancer and Stem Cell Transplant Recipients: A Single‐Center Experience
  di: Adam P. Yan, et al.
  Pubblicazione: (2025)